earnings
CT
NASDAQ · CTXR
Citius Pharmaceuticals, Inc.
Healthcare · Biotechnology
$0.52
Down-$0.04 (-7.56%)
Updated Oct 6, 2026, 11:00 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 12.96M
- P/E ratio
- -0.32
- Dividend yield
- 0.00%
- 52-week range
- $0.47 – $2.19
- Volume
- 132.55K
- Avg. volume
- 805.13K
Price performance · CTXR
CTXR price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
CTXR closed at $0.52 after 20 trading sessions, down 13.41% for the selected period.
- Last close
- $0.52
- Period change
- -13.41%
- Period low
- $0.52
- Period high
- $0.60
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $0.5215 | $0.54 | $0.52 | $0.52 | 132.55K |
| Oct 2, 2026 | $0.533 | $0.5489 | $0.5252 | $0.5316 | 80.51K |
| Oct 1, 2026 | $0.5455 | $0.5678 | $0.53 | $0.5402 | 154.96K |
| Sep 30, 2026 | $0.56 | $0.5694 | $0.5304 | $0.531 | 127.49K |
| Sep 29, 2026 | $0.55 | $0.5596 | $0.55 | $0.5545 | 150.26K |
| Sep 28, 2026 | $0.57 | $0.59 | $0.5258 | $0.549 | 279.61K |
| Sep 25, 2026 | $0.5702 | $0.5957 | $0.5665 | $0.5786 | 65.16K |
| Sep 24, 2026 | $0.57 | $0.5848 | $0.56 | $0.5702 | 154.74K |
| Sep 23, 2026 | $0.6039 | $0.61 | $0.5686 | $0.5686 | 223.14K |
| Sep 22, 2026 | $0.57 | $0.6071 | $0.57 | $0.5982 | 215.27K |
| Sep 21, 2026 | $0.5865 | $0.6019 | $0.5723 | $0.5765 | 155.93K |
| Sep 18, 2026 | $0.60 | $0.6044 | $0.5834 | $0.60 | 284.09K |
| Sep 17, 2026 | $0.5712 | $0.60 | $0.5712 | $0.5879 | 245.9K |
| Sep 16, 2026 | $0.56 | $0.5749 | $0.56 | $0.56 | 139.29K |
| Sep 15, 2026 | $0.58 | $0.585 | $0.56 | $0.5601 | 129.57K |
| Sep 14, 2026 | $0.58 | $0.59 | $0.5701 | $0.5731 | 209.4K |
| Sep 11, 2026 | $0.5856 | $0.595 | $0.5805 | $0.581 | 155.63K |
| Sep 10, 2026 | $0.60 | $0.6099 | $0.5805 | $0.5853 | 164.99K |
| Sep 9, 2026 | $0.601 | $0.61 | $0.5807 | $0.582 | 76.92K |
| Sep 8, 2026 | $0.581 | $0.6169 | $0.5804 | $0.6005 | 310.57K |
Latest CTXR news
The latest Smart Investors Daily articles mentioning CTXR.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

